Development
Novartis AG
NVS
$118.08
$1.241.06%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.07B | 12.82B | 11.07B | 12.19B | 18.73B |
| Total Receivables | 9.25B | 7.10B | 9.54B | 9.18B | 9.80B |
| Inventory | 5.91B | 5.61B | 8.23B | 7.89B | 7.18B |
| Prepaid Expenses | 764.00M | -- | -- | -- | 911.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 484.00M | 20.14B | 4.65B | 2.86B | 297.00M |
| Total Current Assets | 30.48B | 45.66B | 33.49B | 32.11B | 36.91B |
|
|
|||||
| Total Current Assets | 30.48B | 45.66B | 33.49B | 32.11B | 36.91B |
| Net Property, Plant & Equipment | 10.92B | 10.34B | 12.28B | 12.35B | 12.20B |
| Long-term Investments | 23.34B | 23.42B | 29.52B | 29.48B | 29.30B |
| Goodwill | 23.34B | 23.42B | 29.52B | 29.48B | 29.30B |
| Total Other Intangibles | 21.55B | 26.42B | 28.00B | 30.45B | 27.22B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.82B | 5.33B | 5.93B | 6.06B | 10.22B |
| Total Assets | 99.95B | 112.70B | 110.98B | 112.24B | 117.45B |
|
|
|||||
| Total Accounts Payable | 4.93B | 3.87B | 5.35B | 5.43B | 5.15B |
| Total Accrued Expenses | 5.17B | -- | -- | -- | 5.39B |
| Short-term Debt | 3.89B | -- | -- | -- | 3.64B |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.51B | 5.67B | 8.54B | 7.22B | 2.55B |
| Total Finance Division Other Current Liabilities | 9.89B | 38.86B | 18.02B | 17.90B | 11.94B |
| Total Other Current Liabilities | 9.89B | 38.86B | 18.02B | 17.90B | 11.94B |
| Total Current Liabilities | 26.39B | 48.39B | 31.91B | 30.55B | 28.66B |
|
|
|||||
| Total Current Liabilities | 26.39B | 48.39B | 31.91B | 30.55B | 28.66B |
| Long-Term Debt | 18.44B | 18.07B | 18.26B | 20.40B | 20.24B |
| Short-term Debt | 3.89B | -- | -- | -- | 3.64B |
| Capital Leases | 1.60B | 1.45B | 1.55B | 1.59B | 1.54B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.77B | 6.54B | 7.34B | 7.57B | 7.59B |
| Total Liabilities | 53.20B | 74.45B | 59.05B | 60.10B | 58.03B |
|
|
|||||
| Common Stock & APIC | 825.00M | 825.00M | 842.00M | 842.00M | 890.00M |
| Retained Earnings | 49.65B | 42.33B | 55.68B | 56.09B | 63.54B |
| Treasury Stock & Other | -3.81B | -4.99B | -4.68B | -4.87B | -5.09B |
| Total Common Equity | 46.67B | 38.16B | 51.85B | 52.06B | 59.34B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.67B | 38.16B | 51.85B | 52.06B | 59.34B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 83.00M | 81.00M | 84.00M | 83.00M | 81.00M |
| Total Equity | 46.75B | 38.25B | 51.93B | 52.14B | 59.42B |
|
|
|||||